vs

Side-by-side financial comparison of Natera, Inc. (NTRA) and Sensata Technologies Holding plc (ST). Click either name above to swap in a different company.

Sensata Technologies Holding plc is the larger business by last-quarter revenue ($934.8M vs $665.5M, roughly 1.4× Natera, Inc.). Sensata Technologies Holding plc runs the higher net margin — 9.3% vs 7.1%, a 2.2% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 2.6%). Sensata Technologies Holding plc produced more free cash flow last quarter ($104.6M vs $37.8M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs -5.0%).

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

Sensata Technologies Holding plc is a global industrial technology company that designs, manufactures and sells a broad portfolio of sensing, electrical protection and control solutions. Its products serve automotive, industrial, aerospace, HVAC, telecommunications and heavy vehicle end markets, catering to manufacturing and enterprise clients across the world.

NTRA vs ST — Head-to-Head

Bigger by revenue
ST
ST
1.4× larger
ST
$934.8M
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+37.2% gap
NTRA
39.8%
2.6%
ST
Higher net margin
ST
ST
2.2% more per $
ST
9.3%
7.1%
NTRA
More free cash flow
ST
ST
$66.8M more FCF
ST
$104.6M
$37.8M
NTRA
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
-5.0%
ST

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NTRA
NTRA
ST
ST
Revenue
$665.5M
$934.8M
Net Profit
$47.3M
$87.1M
Gross Margin
30.6%
Operating Margin
-3.4%
15.1%
Net Margin
7.1%
9.3%
Revenue YoY
39.8%
2.6%
Net Profit YoY
187.9%
24.6%
EPS (diluted)
$0.36
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NTRA
NTRA
ST
ST
Q1 26
$934.8M
Q4 25
$665.5M
$917.9M
Q3 25
$592.2M
$932.0M
Q2 25
$546.6M
$943.4M
Q1 25
$501.8M
$911.3M
Q4 24
$476.1M
$907.7M
Q3 24
$439.8M
$982.8M
Q2 24
$413.4M
$1.0B
Net Profit
NTRA
NTRA
ST
ST
Q1 26
$87.1M
Q4 25
$47.3M
$63.2M
Q3 25
$-87.5M
$-162.5M
Q2 25
$-100.9M
$60.7M
Q1 25
$-66.9M
$69.9M
Q4 24
$-53.8M
$5.8M
Q3 24
$-31.6M
$-25.0M
Q2 24
$-37.5M
$71.7M
Gross Margin
NTRA
NTRA
ST
ST
Q1 26
30.6%
Q4 25
29.0%
Q3 25
27.8%
Q2 25
30.3%
Q1 25
29.9%
Q4 24
27.1%
Q3 24
28.6%
Q2 24
30.0%
Operating Margin
NTRA
NTRA
ST
ST
Q1 26
15.1%
Q4 25
-3.4%
10.9%
Q3 25
-16.5%
-13.2%
Q2 25
-20.2%
14.6%
Q1 25
-15.8%
13.4%
Q4 24
-13.6%
8.1%
Q3 24
-8.9%
-20.3%
Q2 24
-10.6%
12.5%
Net Margin
NTRA
NTRA
ST
ST
Q1 26
9.3%
Q4 25
7.1%
6.9%
Q3 25
-14.8%
-17.4%
Q2 25
-18.5%
6.4%
Q1 25
-13.3%
7.7%
Q4 24
-11.3%
0.6%
Q3 24
-7.2%
-2.5%
Q2 24
-9.1%
6.9%
EPS (diluted)
NTRA
NTRA
ST
ST
Q1 26
$0.59
Q4 25
$0.36
$0.45
Q3 25
$-0.64
$-1.12
Q2 25
$-0.74
$0.41
Q1 25
$-0.50
$0.47
Q4 24
$-0.41
$0.05
Q3 24
$-0.26
$-0.17
Q2 24
$-0.30
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NTRA
NTRA
ST
ST
Cash + ST InvestmentsLiquidity on hand
$635.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.7B
$2.9B
Total Assets
$2.4B
$6.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NTRA
NTRA
ST
ST
Q1 26
$635.1M
Q4 25
$573.0M
Q3 25
$1.0M
$791.3M
Q2 25
$16.0M
$661.8M
Q1 25
$17.8M
$588.1M
Q4 24
$22.7M
$593.7M
Q3 24
$29.5M
$506.2M
Q2 24
$90.3M
$1.0B
Total Debt
NTRA
NTRA
ST
ST
Q1 26
Q4 25
$2.8B
Q3 25
Q2 25
Q1 25
Q4 24
$3.2B
Q3 24
Q2 24
Stockholders' Equity
NTRA
NTRA
ST
ST
Q1 26
$2.9B
Q4 25
$1.7B
$2.8B
Q3 25
$1.3B
$2.7B
Q2 25
$1.2B
$2.9B
Q1 25
$1.2B
$2.8B
Q4 24
$1.2B
$2.9B
Q3 24
$878.5M
$3.0B
Q2 24
$836.5M
$3.0B
Total Assets
NTRA
NTRA
ST
ST
Q1 26
$6.8B
Q4 25
$2.4B
$6.8B
Q3 25
$1.8B
$7.1B
Q2 25
$1.8B
$7.3B
Q1 25
$1.7B
$7.2B
Q4 24
$1.7B
$7.1B
Q3 24
$1.6B
$7.3B
Q2 24
$1.5B
$8.2B
Debt / Equity
NTRA
NTRA
ST
ST
Q1 26
Q4 25
1.02×
Q3 25
Q2 25
Q1 25
Q4 24
1.11×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NTRA
NTRA
ST
ST
Operating Cash FlowLast quarter
$73.9M
$122.5M
Free Cash FlowOCF − Capex
$37.8M
$104.6M
FCF MarginFCF / Revenue
5.7%
11.2%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
1.56×
1.41×
TTM Free Cash FlowTrailing 4 quarters
$109.1M
$508.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NTRA
NTRA
ST
ST
Q1 26
$122.5M
Q4 25
$73.9M
$201.5M
Q3 25
$59.4M
$159.9M
Q2 25
$37.6M
$140.9M
Q1 25
$44.5M
$119.2M
Q4 24
$52.9M
$170.7M
Q3 24
$51.8M
$130.9M
Q2 24
$4.0M
$143.5M
Free Cash Flow
NTRA
NTRA
ST
ST
Q1 26
$104.6M
Q4 25
$37.8M
$151.9M
Q3 25
$37.0M
$136.2M
Q2 25
$11.7M
$115.5M
Q1 25
$22.6M
$86.6M
Q4 24
$34.8M
$138.9M
Q3 24
$35.5M
$91.3M
Q2 24
$-7.7M
$98.4M
FCF Margin
NTRA
NTRA
ST
ST
Q1 26
11.2%
Q4 25
5.7%
16.6%
Q3 25
6.2%
14.6%
Q2 25
2.1%
12.2%
Q1 25
4.5%
9.5%
Q4 24
7.3%
15.3%
Q3 24
8.1%
9.3%
Q2 24
-1.9%
9.5%
Capex Intensity
NTRA
NTRA
ST
ST
Q1 26
Q4 25
5.4%
5.4%
Q3 25
3.8%
2.5%
Q2 25
4.7%
2.7%
Q1 25
4.3%
3.6%
Q4 24
3.8%
3.5%
Q3 24
3.7%
4.0%
Q2 24
2.8%
4.4%
Cash Conversion
NTRA
NTRA
ST
ST
Q1 26
1.41×
Q4 25
1.56×
3.19×
Q3 25
Q2 25
2.32×
Q1 25
1.70×
Q4 24
29.50×
Q3 24
Q2 24
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons